Zdrowie i gospodarka · 02/04/2014
FDA Releases Draft and Revised Draft Bioequivalence Recommendations for Industry
The Food and Drug Administration (FDA) has made available additional draft and revised draft product-specific bioequivalence recommendations, providing guidance on designing studies to support abbreviated new drug applications (ANDAs).
Source: Federal Register — Food and Drug AdministrationOpen original release →